Partner With an Established Nutraceutical Manufacturing Platform.
Pharma Natural offers investors and strategic partners access to an experienced U.S.-based manufacturing operation with certified quality systems, in-house R&D, accredited laboratory capabilities, packaging, fulfillment, and a scalable B2B manufacturing model.
A platform positioned for scalable expansion.
Pharma Natural is positioned to support growth across private label manufacturing, white-label programs, custom formulation, fulfillment, brand incubation, strategic partnerships, and expanded distribution channels.
With 22+ years of operating history, a certified manufacturing infrastructure, and an integrated operational platform, Pharma Natural represents a differentiated opportunity for investors and strategic partners seeking exposure to the growing U.S. nutraceutical market.
22+ Years Operating
Established 2002. Continuous operations in Miami Lakes, Florida.
Certified Infrastructure
FDA, NSF cGMP, ISO/IEC 17025:2017, WBENC — all active.
300+ Formulations
Broad portfolio across 8 consumer health categories.
Integrated Platform
R&D, QC lab, manufacturing, packaging, and fulfillment in-house.
Flexible structures for diverse investor profiles.
Final structure, terms, valuation, investor rights, and use of funds are subject to company review, legal counsel, and investor diligence.
Investor Diligence Materials Available Upon Request
Selected materials may be shared after internal approval and, where appropriate, NDA.
Commercial Growth Channels Investors Should Understand
These programs represent potential commercial channels and partnership models. Financial performance, margins, capacity, valuation, and growth projections should be confirmed through management-approved investor materials.
Private Label & White Label Supplements
Support for supplement brands, distributors, clinics, retailers, and entrepreneurs seeking ready-to-launch or customized supplement product lines.
Small-MOQ White Label Program
A lower-barrier launch pathway for emerging brands that want to enter the supplement market with existing formulas, professional packaging, and manufacturing support.
Brand Studio Program
An integrated launch program combining product strategy, formulation direction, packaging guidance, label coordination, manufacturing, and fulfillment support.
Distribution Partnership Opportunity
Opportunities for distributors, brokers, retailers, international partners, and institutional buyers to collaborate with Pharma Natural across product categories and market channels.
Creator & Influencer Brand Partnership
A structured pathway for creators, health educators, wellness personalities, and digital communities to launch or promote supplement products with manufacturing and brand support.
Functional Mushroom Gummies
Support for functional mushroom gummy concepts using wellness-oriented ingredients and consumer-friendly delivery formats.
Hemp-Derived Product Manufacturing Support
Manufacturing and quality support for compliant hemp-derived product concepts, with pharmaceutical-style documentation, traceability, testing, and quality protocols where applicable.
Fulfillment & Direct-to-Consumer Support
Warehousing and fulfillment support for brands selling through e-commerce, practitioner channels, subscriptions, and direct-to-consumer models.
Retail-Ready Product Development
Support for brands preparing supplement lines for retail, club stores, pharmacies, wellness chains, specialty stores, and e-commerce distribution.
Disclaimer: This section describes potential business lines and commercial opportunities. It does not represent guaranteed revenue, financial projections, securities offering materials, or investment advice. Actual results depend on management execution, market demand, capacity, pricing, compliance, and partner agreements.
Revenue Channels Supported by the Platform
Pharma Natural's manufacturing platform may support multiple commercial revenue channels across manufacturing, programs, partnerships, product categories, operational services, and strategic growth. These represent potential business lines and commercial opportunities available for qualified partners.
Manufacturing Revenue
Private label supplement manufacturing, white label supplement programs, custom formulation development, gummies, capsules, tablets, powders, and other dosage formats for qualified brand and distribution partners.
Program Revenue
Small-MOQ white label supplement launches, Brand Studio program engagements, creator and influencer brand partnerships, and affiliate referral program introductions for qualified commercial partners.
Partnership Revenue
Supplement distribution partnerships, retail partnerships, wholesale relationships, strategic commercial partnerships, international distribution partners, and institutional buyer relationships.
Product Category Expansion
Functional gummies, mushroom gummies, adaptogen wellness products, and hemp-derived products where legally appropriate, subject to applicable federal, state, ingredient, and regulatory requirements.
Operational Revenue
Packaging coordination, labeling services, warehousing and fulfillment support, third-party lab testing coordination, quality documentation services, and COA workflow support for qualified partners.
Strategic Growth
Investor partnerships, joint ventures, equipment financing arrangements, growth capital relationships, and brand incubation opportunities, subject to management approval, legal review, and applicable securities laws.
Important disclaimer: This section describes potential business lines and commercial opportunities. It does not represent guaranteed revenue, financial projections, securities offering materials, or investment advice. Actual results depend on management execution, market demand, capacity, pricing, compliance, and partner agreements.
Submit Your Investor Inquiry
Complete the form below to begin the conversation. All submissions are reviewed by the Pharma Natural management team.
This website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Any investment opportunity, if pursued, would be subject to management approval, legal review, due diligence, definitive documentation, and applicable securities laws.